Immunotherapy may be more appropriate for ERBB2 low-expressing extramammary paget's disease patients: a prognosis analysis and exploration of targeted therapy and immunotherapy of extramammary paget's disease patients. [PDF]
Cancer Immunol ImmunotherYang J +6 more
europepmc +1 more source
The impact of radiotherapy on disease control in vulvar extramammary Paget's disease: a retrospective study from a single institution. [PDF]
Front OncolSeol A, Kim SI, Song YS.
europepmc +1 more source
Untargeted metabolomics yields insight into extramammary Paget's disease mechanisms. [PDF]
Front OncolJiang L +7 more
europepmc +1 more source
Primary extramammary Paget’s disease with colon cancer
Dermatologica SinicaAnna Takeuchi +2 more
doaj +1 more source
Independent Risk Factors for Postoperative Recurrence of Patients with Primary Extramammary Paget's Disease: A Retrospective Analysis. [PDF]
Clin Cosmet Investig DermatolZhou Z, Chen Y, Tan N, Hu L.
europepmc +1 more source
Phase II clinical trial of docetaxel and trastuzumab for HER2-positive advanced extramammary Paget's disease (EMPD-HER2DOC). [PDF]
OncologistHirai I +9 more
europepmc +1 more source
A case of male extramammary Paget's disease
Asian Journal of SurgeryXuan Qiu +3 more
doaj +1 more source
A Case of Advanced Extramammary Paget's Disease With a High Tumor Mutation Burden That Showed Partial Lymph Node Regression With Pembrolizumab. [PDF]
CureusHorisaki K +4 more
europepmc +1 more source
Clinicopathological Correlation and Recurrence Outcome of Adnexal Involvement on Primary Extramammary Paget's Disease (EMPD). [PDF]
CureusAryal S, Bashyal S, Qiang LY.
europepmc +1 more source